XIENCE V® EECSS

DEVICE2 trials

Sponsors

Abbott Medical Devices

Conditions

Chronic Coronary OcclusionCoronary Artery DiseaseCoronary Artery StenosisCoronary DiseaseCoronary RestenosisMyocardial IschemiaVascular Disease

Phase 4

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

CompletedNCT01171820

Abbott Medical DevicesCoronary Artery Disease, Coronary Disease, Coronary Restenosis

Start: 2006-11-30End: 2010-07-31Updated: 2016-06-27

Unknown Phase

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)

CompletedNCT01120379

Abbott Medical DevicesChronic Coronary Occlusion, Coronary Artery Disease, Coronary Artery Stenosis +4

Start: 2008-07-31End: 2013-12-31Updated: 2015-06-22